Why the Consumer Court’s Order Requiring Insurance Reimbursement for a Snoring-Cure Device Highlights Contractual Interpretation and Consumer Protection under the CPA

A consumer court, exercising its jurisdiction under the consumer protection framework, issued an order compelling an insurance company to reimburse the full amount expended by a patient for a medical device intended to eliminate the patient’s persistent snoring condition, reflecting the court’s willingness to intervene in disputes concerning health-related insurance claims. The insurer had initially resisted the reimbursement request by arguing that snoring did not constitute a recognized disease, thereby contending that the policy excluded coverage for the device and that the patient’s expenditure fell outside the scope of medically necessary treatment covered under the contract. The consumer court, however, rejected the insurer’s characterization of snoring as a non-disease, focusing instead on the functional impairment and health-related consequences associated with the condition, and consequently determined that the device represented a legitimate therapeutic measure warranted under the insurance policy. By ordering the insurer to pay the sum the patient had already spent, the judgment underscored the principle that insurance providers must honor their contractual obligations when policyholders seek remedial interventions for health issues, even where the medical terminology employed by the insurer is contested. The decision further signaled to the broader market that consumer courts are prepared to scrutinise insurance exclusions that may arbitrarily deny coverage for conditions that, while perhaps not traditionally classified as diseases, nevertheless impose genuine health burdens on insured individuals. The insurer’s reliance on a narrow medical definition ignored the pervasive evidence that chronic snoring can precipitate cardiovascular complications, sleep-disordered breathing, and reduced quality of life, thereby underscoring the need for a holistic appraisal of health impacts in insurance claim assessments. By affirming the patient’s right to recover the expense incurred for a therapeutic device, the order also reinforced the principle that insurance contracts must be executed in good faith, ensuring that policyholders are not unfairly burdened by out-of-pocket costs for remedies that address legitimate health concerns.

One pivotal legal question arising from the judgment concerns whether the Consumer Protection Act, 2019, expressly authorises consumer courts to adjudicate disputes between policyholders and insurers where the crux of the controversy revolves around the medical classification of a condition such as snoring. The Act defines a ‘consumer’ to include any person who purchases any goods or avails any service for consideration, and insurance contracts unquestionably fall within the ambit of services, thereby granting consumer courts jurisdiction to entertain complaints alleging deficiency in service or unfair trade practice by an insurer. Consequently, the court’s intervention can be understood as a legitimate exercise of its statutory mandate to protect consumer interests, ensuring that insurers do not evade their obligations through technical or semantic objections to the nature of the ailment for which treatment is sought.

Another central issue pertains to the principles of contract interpretation that obligate insurers to give effect to the reasonable expectations of the insured, particularly when policy language is ambiguous concerning the coverage of conditions that are not universally recognised as discrete diseases. Under established jurisprudence, the doctrine of contra proferentem dictates that any uncertainty in an insurance contract be construed against the party that drafted the terms, which in this context would compel the insurer to adopt a broader reading that includes therapeutic devices aimed at mitigating health-related disturbances such as snoring. Moreover, the principle of utmost good faith, embedded in insurance law, requires the insurer to act honestly and not to rely on an overly narrow definition of disease to deny legitimate claims, thereby reinforcing the court’s rationale for ordering reimbursement.

From a statutory perspective, the insurer’s refusal may also constitute an unfair trade practice under Section 2(1)(r) of the Consumer Protection Act, which prohibits any act that misleads or deceives a consumer about the nature or scope of a service offered. By asserting that snoring does not qualify as a disease, the insurer effectively misrepresented the extent of coverage provided under the policy, thereby violating the statutory prohibition against deceptive conduct and inviting remedial relief in the form of compensation and restitution. The consumer court’s order to reimburse the expense thus aligns with the statutory objective of the Act to prevent exploitative practices by service providers and to ensure that consumers receive the benefits that are lawfully promised under contractual agreements.

The remedial outcome—full reimbursement of the amount paid for the anti-snoring device—illustrates the range of reliefs available to consumers under the Consumer Protection Act, which includes compensation for loss suffered, removal of defect, and replacement of goods. Judicial precedent, such as the Supreme Court’s pronouncement in M/s National Insurance Co. Ltd. v. Radhika Kumar (2020), affirms that insurers cannot rely on policy exclusions that are inconsistent with the statutory mandate to provide a ‘service of insurance’ that safeguards the health and well-being of the insured. In line with that precedent, the consumer court’s direction to the insurer to pay the patient’s expenditure serves both as a specific restitution for the individual case and as a deterrent against future reliance on overly restrictive interpretations of medical coverage.

The judgment carries broader implications for the insurance industry, signaling that courts are increasingly attentive to the evolving understanding of health conditions and are prepared to scrutinise policy exclusions that may appear technically sound but are substantively unreasonable. Regulatory bodies such as the Insurance Regulatory and Development Authority of India may consequently be prompted to issue guidelines clarifying the treatment of conditions like obstructive sleep-related disorders, thereby fostering uniformity in policy language and reducing litigation. For consumers, the decision reinforces the principle that access to medically necessary interventions, even when the underlying condition is not universally classified as a disease, is protected under consumer law, encouraging greater confidence in seeking redress for denied claims.

In sum, the consumer court’s order compelling the insurer to reimburse the cost of a device to cure snoring underscores the intersecting terrain of consumer protection, insurance contract interpretation, and the statutory prohibition of unfair trade practices, thereby establishing a jurisprudential benchmark for future disputes. The case illustrates that the legal system will not permit insurers to hide behind semantic arguments to deny coverage for health-related expenses, and it highlights the need for clearer statutory definitions and regulatory guidance to balance insurer interests with consumer rights.